Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Lung cancer in young females

M. Kreuzer, H.E. Wichmann
European Respiratory Journal 2001 17: 1333; DOI:
M. Kreuzer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.E. Wichmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editor:

We read with interest the article by Lienert et al. 1. Based on data of the clinical cancer registry at the Lungenklinik Heckeshorn, Berlin, 1986–1995, the authors examined whether young female lung cancer patients (≤45 yrs of age, n=96) differ from all other lung cancer patients (n=4,843) with respect to risk factors, histology and clinical features. They found a higher proportion of adenocarcinomas (38%) and carcinoids in young females. Other main characteristics of young females were a high proportion of ever-smokers (88%) and a large number of patients who reported a first degree relative with lung cancer (13%). We would like to add our recent findings of a large-scaled, case-control study of lung cancer conducted in Germany from 1990–1996 2, 3, which aimed to investigate risk factors for lung cancer in young adults. This study included 251 young patients and 280 population controls (≤45 yrs of age), as well as 2,009 older cases and 2,039 older controls (55–69 yrs of age). Adenocarcinomas were more frequent in young males (41%) and young and older females (44% and 47%, respectively) than in older males (28%). Differences in histology between age groups could be explained, in part, by differences in smoking patterns. However, there are still unknown factors that appear to favour the development of adenocarcinoma in the young 3. A history of lung cancer in first degree relatives was associated with a 2.6-fold (95% confidence interval (CI) 1.1–6.0) increased risk in the young, while no elevated risk was observed in the older group (odds ratio=1.2 95% CI 0.9–1.6). Additional evidence for an age-specific genetic predisposition in lung cancer was recently provided by Gauderman and Morrison 4. About 80% of our young female cases were current smokers, demonstrating a 30-fold increased lung cancer risk compared to never-smoking young females 2. As stated by Lienert et al. 1, smoking is the main risk factor for lung cancer in young females. This was recently supported in a pooled analysis of European case-control studies of lung cancer in young females 5, where 84% of female patients aged 40–45 yrs could be attributed to active smoking.

    • © ERS Journals Ltd

    References

    1. ↵
      Lienert T, Serke M, Schönfeld N, Loddenkemper R. Lung cancer in young females. Eur Respir J 2000;16:986–990.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Kreuzer M, Kreienbrock L, Gerken M, et al. Risk factors for lung cancer in young adults. Am J Epidemiol 1998;147:1028–1037.
      OpenUrlAbstract/FREE Full Text
    3. ↵
      Kreuzer M, Kreienbrock L, Müller KM, Gerken M, Wichmann HE. Histologic types of lung carcinoma and age at onset. Cancer 1999;85:1958–1965.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Gauderman WJ, Morrison JL. Evidence for age-specific genetic relative risks in lung cancer. Am J Epidemiol 2000;151:41–49.
      OpenUrlAbstract/FREE Full Text
    5. ↵
      Boffetta P, Kreuzer M, Benhamou S, et al. Risk of lung cancer from tobacco smoking among young women from Europe. Int J Cancer 2001;91:745–746.
      OpenUrlCrossRefPubMedWeb of Science
    PreviousNext
    Back to top
    View this article with LENS
    Vol 17 Issue 6 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Lung cancer in young females
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    Lung cancer in young females
    M. Kreuzer, H.E. Wichmann
    European Respiratory Journal Jun 2001, 17 (6) 1333;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Lung cancer in young females
    M. Kreuzer, H.E. Wichmann
    European Respiratory Journal Jun 2001, 17 (6) 1333;
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Corticosteroids in COVID-19: one size does not fit all
    • Reply: Is high-dose glucocorticoid beneficial in COVID-19?
    • Is high-dose glucocorticoid beneficial in COVID-19?
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2021 by the European Respiratory Society